152 related articles for article (PubMed ID: 38775031)
1. Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB.
Huang Y; Zhang Z; Tong H; Qin W; Li Q; Ma L; Ren Z; Chen W; Zhang Y; Zhong Y; Yao L; Zhou P
J Cell Mol Med; 2024 May; 28(10):e18268. PubMed ID: 38775031
[TBL] [Abstract][Full Text] [Related]
2. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9.
Zhao J; Tang X; Zhu H
Histol Histopathol; 2024 Mar; ():18738. PubMed ID: 38591191
[TBL] [Abstract][Full Text] [Related]
4. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
[TBL] [Abstract][Full Text] [Related]
5. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L
FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
Xu Q; Lin W; Tao C; Huang X; Li J
Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
[TBL] [Abstract][Full Text] [Related]
8. Activation of CHPF by transcription factor NFIC promotes NLRP3 activation during the progression of colorectal cancer.
Wu J; Wang M; Zhang Y; Liu G; Xing Y
Funct Integr Genomics; 2024 Jan; 24(1):20. PubMed ID: 38267731
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA RP11-197K6.1 as ceRNA promotes colorectal cancer progression via miR-135a-5p/DLX5 axis.
Wang M; Niu X; Wang M; Zheng P; Liu X; Cao Z; Zhang C
J Transl Med; 2024 May; 22(1):469. PubMed ID: 38760791
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
Wang D; Feng M; Ma X; Tao K; Wang G
Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
[TBL] [Abstract][Full Text] [Related]
11. The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma.
Luo H; Huang K; Cheng M; Long X; Zhu X; Wu M
Aging (Albany NY); 2023 Oct; 15(20):11052-11066. PubMed ID: 37851364
[TBL] [Abstract][Full Text] [Related]
12. SEZ6L2 knockdown impairs tumour growth by promoting caspase-dependent apoptosis in colorectal cancer.
An N; Zhao Y; Lan H; Zhang M; Yin Y; Yi C
J Cell Mol Med; 2020 Apr; 24(7):4223-4232. PubMed ID: 32105413
[TBL] [Abstract][Full Text] [Related]
13. CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p.
Liu J; Zhang X; Yang M; Zhang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):211. PubMed ID: 38662258
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
15. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
16. Expression of CHPF modulates cell proliferation and invasion in lung cancer.
Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J
Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423
[TBL] [Abstract][Full Text] [Related]
17. DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration.
Tong Y; Huang Y; Zhang Y; Zeng X; Yan M; Xia Z; Lai D
Cell Death Dis; 2021 May; 12(6):529. PubMed ID: 34023852
[TBL] [Abstract][Full Text] [Related]
18. IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins.
Xu X; Wu Y; Yi K; Hu Y; Ding W; Xing C
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907823
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
20. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
